Radiomics
Jeroen Cant is a seasoned technology executive currently serving as Chief Technology Officer at Radiomics.bio, where responsibilities include R&D, strategic partnerships, software development, and IT within the executive team. Concurrently, Jeroen Cant holds advisory positions on the TBM board for Applied Biomedical Research at Research Foundation Flanders and the SBWT5A board for Data Sciences, evaluating grant applications in biomedical research and artificial intelligence. Previous roles include Research Group Lead and Technology Development Manager at Agfa Radiology Solutions, and a PhD researcher at the University of Antwerp focusing on medical 3D reconstruction in collaboration with Agfa. Jeroen Cant's diverse work experience spans from requirements analysis at Agfa HealthCare to project engineering at Altran, supported by a strong educational background including a PhD in Physics from the University of Antwerp and a Master's degree in Electrical Engineering from KU Leuven.
This person is not in any teams
This person is not in any offices
Radiomics
Radiomics is a next generation Liege-based imaging research organization built upon the unparallel experience of its founders, pioneers of the radiomics science. Radiomics focuses on AI powered healthcare, with a unique expertise in Radiomics, Deep Learning & Federated Learning applied to oncology and other therapeutic areas. Through our proprietary advanced image analysis technology, we aim to unravel the gold mine of hidden data information embedded in standard medical images. Our final goal is to support insight-based decision making for optimizing pharmaceutical and biotech companies’ clinical trials and drug development studies and for providing clinicians with a patient-centered approach based on personalized medicine. With this aim, Radiomics’ R&D team is continuously working on new solutions, in collaboration with multiple national and international partners.